Bringing the Oncology Community Together

May 2012: Trials in Progress

The Trials in Progress section supplies summaries of ongoing research in a broad range of cancer types.

Oncology & Biotech News   >   Trials in Progress

More Suicides but Fewer Cardiovascular and Pneumonia Deaths Occurring in Patients With Head and Neck Cancer

US investigators have found that suicide rates in recent years have significantly increased in patients with oral cavity and oropharyngeal cancer.

Oncology & Biotech News   >   Clinical Trial Reports

Erin McMenamin on HPV-related Head & Neck Cancer

Erin McMenamin, MSN, from the Hospital of the University of Pennsylvania, on HPV-related Head & Neck Cancer Prognosis

Conferences   >   2012 Oncology Nursing Society Congress

Oncology Nurses Can Help Mitigate Treatment-Related Side Effects in Head and Neck Cancers

Treatment of head and neck cancer often leaves patients with aftereffects that are bothersome at the very least and life-altering at their worst.

Conferences   >   2012 Oncology Nursing Society Congress

Robotic Surgery Is Useful Option for Oral Cancer

Minimally invasive transoral robotic surgery, used alone or combined with adjuvant therapy, provides good functional and oncologic outcomes in patients with oropharyngeal squamous cell carcinoma.

Oncology & Biotech News   >   Clinical Trial Reports

Hypothyroidism Risks With MKIs Examined

A retrospective analysis of the risks of hypothyroidism in patients who received sunitinib and sorafenib is gaining attention in the field of head and neck cancers.

Oncology Live   >   Clinical Insights

April 2012: Trials in Progress

The Trials in Progress section supplies summaries of ongoing research in a broad range of cancer types.

Oncology & Biotech News   >   Trials in Progress

Surviving Brain Cancer During Pregnancy

Antonia Reyes was 39 years old and 18 weeks pregnant when an MRI revealed an apparent glioma in the right temporal-parietal lobe region.

OncLive Nursing   >   Patient Focus

New Indicator May Help Identify Patients With Increased Risk From Throat Cancer

Patients with oropharyngeal squamous cell carcinoma who had matted lymph nodes -- nodes that are connected together -- are more likely to metastasize than those without matted lymph nodes.

Oncology & Biotech News   >   News

Oral HPV Infection Affects 7% of the US Population

Approximately 7% of Americans are infected with oral human papillomavirus (HPV), and men are 3 times as likely to be infected as women.

Oncology Live   >   Specialty Focus

Acupuncture Shows Potential for Xerostomia

Acupuncture may help prevent xerostomia in patients with nasopharyngeal carcinoma undergoing radiotherapy and may also reduce symptom severity.

Oncology & Biotech News   >   Clinical Trial Reports

HPV Plays Growing Role in Evaluating Therapies

Researchers are dissecting new studies regarding targeted therapies as well as combined therapeutic approaches for HPV in the progression of head and neck cancers.

Oncology Live   >   Specialty Focus

Addition of Bevacizumab May Help in Nasopharyngeal Cancer

Researchers are reporting favorable early results with the addition of bevacizumab to conventional chemoradiation in patients with advanced nasopharyngeal cancer.

Oncology Live   >   Specialty Focus

HPV and the Rise of Head and Neck Cancers

Human papillomavirus is perhaps best known as the main cause of cervical cancer, but if recent trends continue, by 2020 HPV will cause more cases of oropharyngeal cancer each year than cervical cancer.

Oncology & Biotech News   >   Feature Article

Mouth Care Systems Alleviate Xerostomia After Radiotherapy

Radiotherapy often results in the loss of some salivary gland function, causing hyposalivation and xerostomia.

Oncology & Biotech News   >   News

Oral HPV Infections More Prevalent in Men

Approximately 7% of Americans carry the human papillomavirus (HPV) in their oral cavities, and men are 3 times more likely to carry the virus than women.

  >   Web Exclusives

Minimally Invasive Surgeries Retain Place in Treatment Plan

In an era when advances in chemoradiation and targeted therapies have revolutionized treatment in head and neck oncology patients, it's possible that treating physicians might not know where surgery fits into the regimen.

Oncology Live   >   Specialty Focus

Clinical Management of Primary Brain Tumors

At NCONN 2011, Sean Grimm, MD, discussed the management of Glioblastoma multiforme, the most common malignant primary brain tumor.

OncLive Nursing   >   Conference Highlights

Chemoradiotherapy Shows Promise in Nonmelanoma Skin Cancer of the Head and Neck

Chemotherapy given at the same time as radiotherapy may be a feasible treatment for high-risk nonmelanoma skin cancer (NMSC) of the head and neck.

Oncology & Biotech News   >   Clinical Trial Reports

Hair Professionals Often Check Customers for Worrisome Skin Lesions

Some cosmetologists and barbers inspect their customers' scalps, necks, and faces for the presence of skin lesions that they think may be cancerous.

Oncology & Biotech News   >   Clinical Trial Reports